These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
136 related items for PubMed ID: 20920896
1. Improved early diagnosis of Pseudomonas aeruginosa by real-time PCR to prevent chronic colonisation in a paediatric cystic fibrosis population. McCulloch E, Lucas C, Ramage G, Williams C. J Cyst Fibros; 2011 Jan; 10(1):21-4. PubMed ID: 20920896 [Abstract] [Full Text] [Related]
2. Evaluation of the efficacy of real-time polymerase chain reaction for the routine early detection of Pseudomonas aeruginosa in cystic fibrosis sputum and throat swab specimens. Logan C, Habington A, Lennon G, Cronin F, O'Sullivan N. Diagn Microbiol Infect Dis; 2010 Dec; 68(4):358-65. PubMed ID: 20884156 [Abstract] [Full Text] [Related]
3. Pseudomonas aeruginosa and Burkholderia cepacia cannot be detected by PCR in the breath condensate of patients with cystic fibrosis. Vogelberg C, Hirsch T, Rösen-Wolff A, Kerkmann ML, Leupold W. Pediatr Pulmonol; 2003 Oct; 36(4):348-52. PubMed ID: 12950050 [Abstract] [Full Text] [Related]
4. The combination of PCR and serology increases the diagnosis of Pseudomonas aeruginosa colonization/infection in cystic fibrosis. da Silva Filho LV, Tateno AF, Martins KM, Azzuz Chernishev AC, Garcia Dde O, Haug M, Meisner C, Rodrigues JC, Döring G. Pediatr Pulmonol; 2007 Oct; 42(10):938-44. PubMed ID: 17722007 [Abstract] [Full Text] [Related]
5. Phenotypic & genotypic variants of Pseudomonas aeruginosa isolated from children with cystic fibrosis in India. Agarwal G, Kapil A, Kabra SK, Chandra R, Das B, Diwedi SN. Indian J Med Res; 2002 Aug; 116():73-81. PubMed ID: 12592994 [Abstract] [Full Text] [Related]
6. Polymerase chain reaction for the detection of Pseudomonas aeruginosa, Stenotrophomonas maltophilia and Burkholderia cepacia in sputum of patients with cystic fibrosis. Karpati F, Jonasson J. Mol Cell Probes; 1996 Dec; 10(6):397-403. PubMed ID: 9025076 [Abstract] [Full Text] [Related]
7. [Detection and management of early Pseudomonas aeruginosa infection in patients with cystic fibrosis]. Kernen Y, Sauty A, Roulet M. Rev Med Suisse; 2005 Mar 02; 1(9):637-8, 640. PubMed ID: 15813341 [Abstract] [Full Text] [Related]
8. Regimens for eradicating early Pseudomonas aeruginosa infection in children do not promote antibiotic resistance in this organism. Ho SA, Lee TW, Denton M, Conway SP, Brownlee KG. J Cyst Fibros; 2009 Jan 02; 8(1):43-6. PubMed ID: 18829398 [Abstract] [Full Text] [Related]
9. Achromobacter xylosoxidans in cystic fibrosis: prevalence and clinical relevance. De Baets F, Schelstraete P, Van Daele S, Haerynck F, Vaneechoutte M. J Cyst Fibros; 2007 Jan 02; 6(1):75-8. PubMed ID: 16793350 [Abstract] [Full Text] [Related]
10. Approaches to the treatment of initial Pseudomonas aeruginosa infection in children who have cystic fibrosis. Lahiri T. Clin Chest Med; 2007 Jun 02; 28(2):307-18. PubMed ID: 17467550 [Abstract] [Full Text] [Related]
11. Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience. Hansen CR, Pressler T, Høiby N. J Cyst Fibros; 2008 Nov 02; 7(6):523-30. PubMed ID: 18693078 [Abstract] [Full Text] [Related]
12. Effect of mutator P. aeruginosa on antibiotic resistance acquisition and respiratory function in cystic fibrosis. Ferroni A, Guillemot D, Moumile K, Bernede C, Le Bourgeois M, Waernessyckle S, Descamps P, Sermet-Gaudelus I, Lenoir G, Berche P, Taddei F. Pediatr Pulmonol; 2009 Aug 02; 44(8):820-5. PubMed ID: 19598278 [Abstract] [Full Text] [Related]
13. Controlled trial of cycled antibiotic prophylaxis to prevent initial Pseudomonas aeruginosa infection in children with cystic fibrosis. Tramper-Stranders GA, Wolfs TF, van Haren Noman S, van Aalderen WM, Nagelkerke AF, Nuijsink M, Kimpen JL, van der Ent CK. Thorax; 2010 Oct 02; 65(10):915-20. PubMed ID: 20729233 [Abstract] [Full Text] [Related]
14. Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients. Cantón R, Cobos N, de Gracia J, Baquero F, Honorato J, Gartner S, Alvarez A, Salcedo A, Oliver A, García-Quetglas E, Spanish Consensus Group for Antimicrobial Therapy in the Cystic Fibrosis Patient. Clin Microbiol Infect; 2005 Sep 02; 11(9):690-703. PubMed ID: 16104983 [Abstract] [Full Text] [Related]
15. Treatment of early Pseudomonas aeruginosa infection in patients with cystic fibrosis: the ELITE trial. Ratjen F, Munck A, Kho P, Angyalosi G, ELITE Study Group. Thorax; 2010 Apr 02; 65(4):286-91. PubMed ID: 19996339 [Abstract] [Full Text] [Related]